{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:22:10Z","timestamp":1792178530866,"version":"4.4.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"15","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R43 HL120645"],"award-info":[{"award-number":["R43 HL120645"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44 AG054386"],"award-info":[{"award-number":["R44 AG054386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Acute myocardial infarction (MI) causes inflammation, collagen deposition, and reparative fibrosis in response to myocyte death and, subsequently, a pathological myocardial remodelling process characterized by excessive interstitial fibrosis, driving heart failure (HF). Nonetheless, how or when to limit excessive fibrosis for therapeutic purposes remains uncertain. Galectin-3, a major mediator of organ fibrosis, promotes cardiac fibrosis and remodelling. We performed a preclinical assessment of a protein inhibitor of galectin-3 (its C-terminal domain, Gal-3C) to limit excessive fibrosis resulting from MI and prevent ventricular enlargement and HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Gal-3C was produced by enzymatic cleavage of full-length galectin-3 or by direct expression of the truncated form in Escherichia coli. Gal-3C was intravenously administered for 7 days in acute MI models of young and aged rats, starting either pre-MI or 4 days post-MI. Echocardiography, haemodynamics, histology, and molecular and cellular analyses were performed to assess post-MI cardiac functionality and pathological fibrotic progression. Gal-3C profoundly benefitted left ventricular ejection fraction, end-systolic and end-diastolic volumes, haemodynamic parameters, infarct scar size, and interstitial fibrosis, with better therapeutic efficacy than losartan and spironolactone monotherapies over the 56-day study. Gal-3C therapy in post-MI aged rats substantially improved pump function and attenuated ventricular dilation, preventing progressive HF. Gal-3C in vitro treatment of M2-polarized macrophage-like cells reduced their M2-phenotypic expression of arginase-1 and interleukin-10. Gal-3C inhibited M2 polarization of cardiac macrophages during reparative response post-MI. Gal-3C impeded progressive fibrosis post-MI by down-regulating galectin-3-mediated profibrotic signalling cascades including a reduction in endogenous arginase-1 and inducible nitric oxide synthase (iNOS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Gal-3C treatment improved long-term cardiac function post-MI by reduction in the wound-healing response, and inhibition of inflammatory fibrogenic signalling to avert an augmentation of fibrosis in the periinfarct region. Thus, Gal-3C treatment prevented the infarcted heart from extensive fibrosis that accelerates the development of HF, providing a potential targeted therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cvr\/cvad116","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T23:57:56Z","timestamp":1690847876000},"page":"2536-2549","source":"Crossref","is-referenced-by-count":51,"title":["Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades"],"prefix":"10.1093","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6667-5209","authenticated-orcid":false,"given":"Xiaoyin","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Cardiology, University of California , San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 , USA"},{"name":"Cardiovascular Research Institute, University of California , San Francisco, 555 Mission Bay Boulevard South, San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Gaur","sequence":"additional","affiliation":[{"name":"MandalMed, Inc. , 665 3rd Street, Suite 250, San Francisco, CA 94107 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Mounzih","sequence":"additional","affiliation":[{"name":"MandalMed, Inc. , 665 3rd Street, Suite 250, San Francisco, CA 94107 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda J","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California , San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 , USA"},{"name":"Cardiovascular Research Institute, University of California , San Francisco, 555 Mission Bay Boulevard South, San Francisco, CA 94158 , USA"},{"name":"MandalMed, Inc. , 665 3rd Street, Suite 250, San Francisco, CA 94107 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiliang","family":"Qiu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California , San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 , USA"},{"name":"Cardiovascular Research Institute, University of California , San Francisco, 555 Mission Bay Boulevard South, San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California , San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiu","family":"Yan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California , San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A","family":"Cooper","sequence":"additional","affiliation":[{"name":"MandalMed, Inc. , 665 3rd Street, Suite 250, San Francisco, CA 94107 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Narayan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California , San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 , USA"},{"name":"Cardiovascular Research Institute, University of California , San Francisco, 555 Mission Bay Boulevard South, San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Derakhshandeh","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California , San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 , USA"},{"name":"Cardiovascular Research Institute, University of California , San Francisco, 555 Mission Bay Boulevard South, San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Rao","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California , San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 , USA"},{"name":"Cardiovascular Research Institute, University of California , San Francisco, 555 Mission Bay Boulevard South, San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D","family":"Han","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California , San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooneh","family":"Nabavizadeh","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California , San Francisco, 555 Mission Bay Boulevard South, San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-8234","authenticated-orcid":false,"given":"Matthew L","family":"Springer","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California , San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 , USA"},{"name":"Cardiovascular Research Institute, University of California , San Francisco, 555 Mission Bay Boulevard South, San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-6325","authenticated-orcid":false,"given":"Constance M","family":"John","sequence":"additional","affiliation":[{"name":"MandalMed, Inc. , 665 3rd Street, Suite 250, San Francisco, CA 94107 , USA"},{"name":"Department of Laboratory Medicine, University of California , San Francisco, 185 Berry Street, Suite 100, San Francisco, CA 94143 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"2023112604541487700_cvad116-B1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"2023112604541487700_cvad116-B2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ejhf.1406","article-title":"Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology","volume":"21","author":"de Boer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2023112604541487700_cvad116-B3","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/01.CIR.89.5.2273","article-title":"Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat","volume":"89","author":"Schieffer","year":"1994","journal-title":"Circulation"},{"key":"2023112604541487700_cvad116-B4","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","article-title":"Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis","volume":"99","author":"Silvestre","year":"1999","journal-title":"Circulation"},{"key":"2023112604541487700_cvad116-B5","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.4049\/jimmunol.180.4.2650","article-title":"Regulation of alternative macrophage activation by galectin-3","volume":"180","author":"MacKinnon","year":"2008","journal-title":"J Immunol"},{"key":"2023112604541487700_cvad116-B6","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"2023112604541487700_cvad116-B7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","article-title":"The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries","volume":"3","author":"Calvier","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2023112604541487700_cvad116-B8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7150\/thno.22196","article-title":"Galectin-3 activation and inhibition in heart failure and cardiovascular disease: an update","volume":"8","author":"Suthahar","year":"2018","journal-title":"Theranostics"},{"key":"2023112604541487700_cvad116-B9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","article-title":"Regulation of transforming growth factor-\u03b21-driven lung fibrosis by galectin-3","volume":"185","author":"Mackinnon","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2023112604541487700_cvad116-B10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2010.538080","article-title":"Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction","volume":"43","author":"de Boer","year":"2011","journal-title":"Ann Med"},{"key":"2023112604541487700_cvad116-B11","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.jacc.2019.02.046","article-title":"Galectin-3 levels and outcomes after myocardial infarction: a population-based study","volume":"73","author":"Asleh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023112604541487700_cvad116-B12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3909\/ricm0624","article-title":"Galectin-3: a novel blood test for the evaluation and management of patients with heart failure","volume":"12","author":"McCullough","year":"2011","journal-title":"Rev Cardiovasc Med"},{"key":"2023112604541487700_cvad116-B13","first-page":"2374","article-title":"Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer","volume":"9","author":"John","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2023112604541487700_cvad116-B14","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/j.ijcard.2013.12.129","article-title":"Galectin-3 expression in cardiac remodeling after myocardial infarction","volume":"172","author":"Sanchez-Mas","year":"2014","journal-title":"Int J Cardiol"},{"key":"2023112604541487700_cvad116-B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","article-title":"Myofibroblast-mediated mechanisms of pathological remodelling of the heart","volume":"10","author":"Weber","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"2023112604541487700_cvad116-B16","first-page":"158","article-title":"Aging and cardiac fibrosis","volume":"2","author":"Biernacka","year":"2011","journal-title":"Aging Dis"},{"key":"2023112604541487700_cvad116-B17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fimmu.2014.00479","article-title":"\u201cOf mice and men\u201d: arginine metabolism in macrophages","volume":"5","author":"Thomas","year":"2014","journal-title":"Front Immunol"},{"key":"2023112604541487700_cvad116-B18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/joim.13358","article-title":"Arginase 1 is upregulated at admission in patients with ST-elevation myocardial infarction","volume":"290","author":"Tengbom","year":"2021","journal-title":"J Intern Med"},{"key":"2023112604541487700_cvad116-B19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00395-017-0609-2","article-title":"Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure","volume":"112","author":"Kingery","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"2023112604541487700_cvad116-B20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-5273(00)00394-6","article-title":"Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat","volume":"76","author":"Takimoto","year":"2000","journal-title":"Int J Cardiol"},{"key":"2023112604541487700_cvad116-B21","doi-asserted-by":"crossref","first-page":"11794","DOI":"10.1073\/pnas.1116584109","article-title":"Cardiomyocyte-specific I\u03baB kinase (IKK)\/NF-\u03baB activation induces reversible inflammatory cardiomyopathy and heart failure","volume":"109","author":"Maier","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023112604541487700_cvad116-B22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/08830185.2014.911855","article-title":"Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?","volume":"33","author":"Mirandola","year":"2014","journal-title":"Int Rev Immunol"},{"key":"2023112604541487700_cvad116-B23","doi-asserted-by":"crossref","first-page":"100ra90","DOI":"10.1126\/scitranslmed.3002814","article-title":"Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response","volume":"3","author":"Wang","year":"2011","journal-title":"Sci Transl Med"},{"key":"2023112604541487700_cvad116-B24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2023112604541487700_cvad116-B25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages","volume":"5","author":"Rath","year":"2014","journal-title":"Front Immunol"},{"key":"2023112604541487700_cvad116-B26","doi-asserted-by":"crossref","first-page":"L34","DOI":"10.1152\/ajplung.00007.2007","article-title":"Functional role and species-specific contribution of arginases in pulmonary fibrosis","volume":"294","author":"Kitowska","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2023112604541487700_cvad116-B27","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.4049\/jimmunol.1600476","article-title":"IL-6 regulates M2 polarization and local proliferation of adipose tissue macrophages in obesity","volume":"198","author":"Braune","year":"2017","journal-title":"J Immunol"},{"key":"2023112604541487700_cvad116-B28","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1053\/euhj.1999.1580","article-title":"Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-\u03b1","volume":"20","author":"Comini","year":"1999","journal-title":"Eur Heart J"},{"key":"2023112604541487700_cvad116-B29","doi-asserted-by":"crossref","first-page":"eabe4932","DOI":"10.1126\/scisignal.abe4932","article-title":"NF-\u03baB activation in cardiac fibroblasts results in the recruitment of inflammatory Ly6C(hi) monocytes in pressure-overloaded hearts","volume":"14","author":"Abe","year":"2021","journal-title":"Sci Signal"},{"key":"2023112604541487700_cvad116-B30","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1038\/s41598-019-46119-6","article-title":"Myocardial injury after ischemia\/reperfusion is attenuated by pharmacological galectin-3 inhibition","volume":"9","author":"Ibarrola","year":"2019","journal-title":"Sci Rep"},{"key":"2023112604541487700_cvad116-B31","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2019.11.296","article-title":"Effects of belapectin, an inhibitor of galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension","volume":"158","author":"Chalasani","year":"2020","journal-title":"Gastroenterology"},{"key":"2023112604541487700_cvad116-B32","doi-asserted-by":"crossref","first-page":"H45","DOI":"10.1152\/ajpheart.00609.2018","article-title":"Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling","volume":"316","author":"Nguyen","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023112604541487700_cvad116-B33","doi-asserted-by":"crossref","first-page":"21751","DOI":"10.1074\/jbc.C112.358002","article-title":"Ligand induced galectin-3 protein self-association","volume":"287","author":"Lepur","year":"2012","journal-title":"J Biol Chem"},{"key":"2023112604541487700_cvad116-B34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/JLB.3A0317-110R","article-title":"Galectin-3 type-C self-association on neutrophil surfaces; the carbohydrate recognition domain regulates cell function","volume":"103","author":"Sundqvist","year":"2018","journal-title":"J Leukoc Biol"},{"key":"2023112604541487700_cvad116-B35","doi-asserted-by":"crossref","first-page":"14167","DOI":"10.1016\/S0021-9258(19)49693-2","article-title":"Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin","volume":"267","author":"Hsu","year":"1992","journal-title":"J Biol Chem"},{"key":"2023112604541487700_cvad116-B36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-4165(97)00086-X","article-title":"Modulation of the biological functions of galectin-3 by matrix metalloproteinases","volume":"1379","author":"Ochieng","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"2023112604541487700_cvad116-B37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13550-014-0075-x","article-title":"Labeling galectin-3 for the assessment of myocardial infarction in rats","volume":"4","author":"Arias","year":"2014","journal-title":"EJNMMI Res"},{"key":"2023112604541487700_cvad116-B38","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbagen.2012.02.018","article-title":"Galectin-3 endocytosis by carbohydrate independent and dependent pathways in different macrophage like cell types","volume":"1820","author":"Lepur","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2023112604541487700_cvad116-B39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/bk-2012-1115.ch012","volume-title":"Galectins and Disease Implications for Targeted Therapeutics","author":"Jarvis","year":"2012"},{"key":"2023112604541487700_cvad116-B40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvu025","article-title":"Cardiac macrophages and their role in ischaemic heart disease","volume":"102","author":"Frantz","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2023112604541487700_cvad116-B41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0008-6363(02)00413-3","article-title":"Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats","volume":"55","author":"Deten","year":"2002","journal-title":"Cardiovasc Res"},{"key":"2023112604541487700_cvad116-B42","doi-asserted-by":"crossref","first-page":"23010","DOI":"10.1038\/srep23010","article-title":"Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFbeta1 and miR-29 pathways","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"2023112604541487700_cvad116-B43","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacc.2013.05.078","article-title":"Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"62","author":"Liu","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvad116\/51125645\/cvad116.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/119\/15\/2536\/53812187\/cvad116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/119\/15\/2536\/53812187\/cvad116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T23:54:56Z","timestamp":1700956496000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/119\/15\/2536\/7243735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":43,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8,21]]},"published-print":{"date-parts":[[2023,11,25]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvad116","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,8,21]]}}}